Disc Medicine (IRON) Earnings Analysis
Disc Medicine (IRON) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS -1.62 USD vs -1.69 USD est (+4.1%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -11.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IRON next report earnings?
No confirmed upcoming earnings date is currently scheduled for IRON. This page updates as the calendar is published.
IRON earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -1.62 USD | -1.69 USD | +4.1% | Beat |
| 2025-11-06 | -1.77 USD | -1.48 USD | -19.6% | Miss |
| 2025-08-07 | -1.58 USD | -1.17 USD | -35% | Miss |
| 2025-02-27 | -0.98 USD | -1.06 USD | +7.5% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
IRON valuation and analyst view
| Trailing P/E | -11.19 |
|---|---|
| Trailing EPS | -6.2768 USD |
| Price / book | 4.16 |
| Dividend yield | 0.00% |
| Market cap | 2.83B |
| Analyst consensus | Buy (11 buy / 0 hold / 0 sell) |
| Avg price target | 82.5 USD |
Related research pages
Frequently asked questions
When is Disc Medicine (IRON)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for IRON. This page updates as the calendar is published.
Did IRON beat earnings last quarter?
In its 2026-02-26 report, IRON posted EPS of -1.62 USD versus a -1.69 USD estimate — a beat of 4.1%.
What is IRON's earnings track record?
Over the last 4 reported quarters with consensus data, IRON beat estimates 2 times (50%).
What is IRON's current P/E ratio and EPS?
IRON trades at a trailing P/E of -11.19 on trailing EPS of -6.276799307523833 USD.
What do analysts rate IRON?
Analyst consensus is "Buy" across 11 ratings (1 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 82.5 USD.